The rising prevalence in GLP-1 agonists for metabolic health has sparked a discussion about delivery routes : skin-applied devices versus capsules. Usually , GLP-1 drugs were only available in tablet https://gerardzclf186792.canariblogs.com/glp-1-skin-applications-vs-tablets-what-suitable-for-the-patient-55876861